Percheron Therapeutics Limited ANP.AX Stock
Percheron Therapeutics Limited Price Chart
Percheron Therapeutics Limited ANP.AX Financial and Trading Overview
| Percheron Therapeutics Limited stock price | 0.06 AUD |
| Previous Close | 0.07 AUD |
| Open | 0.07 AUD |
| Bid | 0.07 AUD x 0 |
| Ask | 0.07 AUD x 0 |
| Day's Range | 0.07 - 0.07 AUD |
| 52 Week Range | 0.06 - 0.15 AUD |
| Volume | 660.1K AUD |
| Avg. Volume | 490.53K AUD |
| Market Cap | 46.85M AUD |
| Beta (5Y Monthly) | 0.643678 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANP.AX Valuation Measures
| Enterprise Value | 35.75M AUD |
| Trailing P/E | N/A |
| Forward P/E | -3.5 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 23.299034 |
| Price/Book (mrq) | 2.9166667 |
| Enterprise Value/Revenue | 17.777 |
| Enterprise Value/EBITDA | -4.405 |
Trading Information
Percheron Therapeutics Limited Stock Price History
| Beta (5Y Monthly) | 0.643678 |
| 52-Week Change | -16.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 AUD |
| 52 Week Low | 0.06 AUD |
| 50-Day Moving Average | 0.07 AUD |
| 200-Day Moving Average | 0.09 AUD |
ANP.AX Share Statistics
| Avg. Volume (3 month) | 490.53K AUD |
| Avg. Daily Volume (10-Days) | 725.24K AUD |
| Shares Outstanding | 669.32M |
| Float | 532.59M |
| Short Ratio | N/A |
| % Held by Insiders | 20.28% |
| % Held by Institutions | 4.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -404.024% |
| Gross Margin | 97.94% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.51% |
| Return on Equity (ttm) | -40.55% |
Income Statement
| Revenue (ttm) | 2.01M AUD |
| Revenue Per Share (ttm) | 0.003 AUD |
| Quarterly Revenue Growth (yoy) | 89.50% |
| Gross Profit (ttm) | 1.71M AUD |
| EBITDA | -8115440 AUD |
| Net Income Avi to Common (ttm) | -8102384 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.62M AUD |
| Total Cash Per Share (mrq) | 0.03 AUD |
| Total Debt (mrq) | 185.37K AUD |
| Total Debt/Equity (mrq) | 1.16 AUD |
| Current Ratio (mrq) | 8.998 |
| Book Value Per Share (mrq) | 0.024 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6765062 AUD |
| Levered Free Cash Flow (ttm) | -3775655 AUD |
Profile of Percheron Therapeutics Limited
| Country | Australia |
| State | VIC |
| City | Toorak |
| Address | 14 Wallace Avenue |
| ZIP | 3142 |
| Phone | 61 3 9827 8999 |
| Website | https://www.antisense.com.au |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase II clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.
Q&A For Percheron Therapeutics Limited Stock
What is a current ANP.AX stock price?
Percheron Therapeutics Limited ANP.AX stock price today per share is 0.06 AUD.
How to purchase Percheron Therapeutics Limited stock?
You can buy ANP.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Percheron Therapeutics Limited?
The stock symbol or ticker of Percheron Therapeutics Limited is ANP.AX.
Which industry does the Percheron Therapeutics Limited company belong to?
The Percheron Therapeutics Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Percheron Therapeutics Limited have in circulation?
The max supply of Percheron Therapeutics Limited shares is 901.54M.
What is Percheron Therapeutics Limited Price to Earnings Ratio (PE Ratio)?
Percheron Therapeutics Limited PE Ratio is 0.00000000 now.
What was Percheron Therapeutics Limited earnings per share over the trailing 12 months (TTM)?
Percheron Therapeutics Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Percheron Therapeutics Limited company belong to?
The Percheron Therapeutics Limited sector is Healthcare.